158 related articles for article (PubMed ID: 28685176)
1. The hormetic functions of Wnt pathways in tubular injury.
Gröne EF; Federico G; Nelson PJ; Arnold B; Gröne HJ
Pflugers Arch; 2017 Aug; 469(7-8):899-906. PubMed ID: 28685176
[TBL] [Abstract][Full Text] [Related]
2. Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.
Federico G; Meister M; Mathow D; Heine GH; Moldenhauer G; Popovic ZV; Nordström V; Kopp-Schneider A; Hielscher T; Nelson PJ; Schaefer F; Porubsky S; Fliser D; Arnold B; Gröne HJ
JCI Insight; 2016 Jan; 1(1):e84916. PubMed ID: 27699213
[TBL] [Abstract][Full Text] [Related]
3. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner.
Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X
Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264
[TBL] [Abstract][Full Text] [Related]
4. Dickkopf 3-a novel biomarker of the 'kidney injury continuum'.
Schunk SJ; Speer T; Petrakis I; Fliser D
Nephrol Dial Transplant; 2021 Apr; 36(5):761-767. PubMed ID: 32025732
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor induces tubular epithelial to mesenchymal transition through the activation of canonical Wnt signaling in vitro.
Yang Z; Sun L; Nie H; Liu H; Liu G; Guan G
Ren Fail; 2015 Feb; 37(1):129-35. PubMed ID: 25296105
[TBL] [Abstract][Full Text] [Related]
6. WNT-β-catenin signalling - a versatile player in kidney injury and repair.
Schunk SJ; Floege J; Fliser D; Speer T
Nat Rev Nephrol; 2021 Mar; 17(3):172-184. PubMed ID: 32989282
[TBL] [Abstract][Full Text] [Related]
7. Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.
Zewinger S; Rauen T; Rudnicki M; Federico G; Wagner M; Triem S; Schunk SJ; Petrakis I; Schmit D; Wagenpfeil S; Heine GH; Mayer G; Floege J; Fliser D; Gröne HJ; Speer T
J Am Soc Nephrol; 2018 Nov; 29(11):2722-2733. PubMed ID: 30279273
[TBL] [Abstract][Full Text] [Related]
8. Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
Zhang L; Sun C; Jin Y; Gao K; Shi X; Qiu W; Ma C; Zhang L
J Alzheimers Dis; 2017; 60(2):733-746. PubMed ID: 28922151
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-1 Acts as a Profibrotic Mediator in Progressive Chronic Kidney Disease.
Hsu YC; Chang CC; Hsieh CC; Huang YT; Shih YH; Chang HC; Chang PJ; Lin CL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108841
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease.
Huffstater T; Merryman WD; Gewin LS
Semin Nephrol; 2020 Mar; 40(2):126-137. PubMed ID: 32303276
[TBL] [Abstract][Full Text] [Related]
11. Chronic exposure to nanoparticulate TiO2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney.
Hong F; Hong J; Wang L; Zhou Y; Liu D; Xu B; Yu X; Sheng L
J Agric Food Chem; 2015 Feb; 63(5):1639-47. PubMed ID: 25603832
[TBL] [Abstract][Full Text] [Related]
12. Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.
Nakagawa S; Nishihara K; Miyata H; Shinke H; Tomita E; Kajiwara M; Matsubara T; Iehara N; Igarashi Y; Yamada H; Fukatsu A; Yanagita M; Matsubara K; Masuda S
PLoS One; 2015; 10(8):e0136994. PubMed ID: 26317775
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?
Hamzehzadeh L; Caraglia M; Atkin SL; Sahebkar A
J Cell Physiol; 2018 Jun; 233(6):4595-4605. PubMed ID: 29206297
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Dickkopf-3 Serum and Urine Levels at Different Stages of Chronic Kidney Disease.
Dziamałek-Macioszczyk P; Winiarska A; Pawłowska A; Wojtacha P; Stompór T
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510820
[TBL] [Abstract][Full Text] [Related]
16. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease].
Nakagawa S
Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371
[TBL] [Abstract][Full Text] [Related]
17. Dickkopf-3: Current Knowledge in Kidney Diseases.
Fang X; Hu J; Chen Y; Shen W; Ke B
Front Physiol; 2020; 11():533344. PubMed ID: 33391006
[TBL] [Abstract][Full Text] [Related]
18. Tubular atrophy in the pathogenesis of chronic kidney disease progression.
Schelling JR
Pediatr Nephrol; 2016 May; 31(5):693-706. PubMed ID: 26208584
[TBL] [Abstract][Full Text] [Related]
19. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease.
Schunk SJ; Beisswenger C; Ritzmann F; Herr C; Wagner M; Triem S; Hütter G; Schmit D; Zewinger S; Sarakpi T; Honecker A; Mahadevan P; Boor P; Wagenpfeil S; Jörres R; Watz H; Welte T; Vogelmeier CF; Gröne HJ; Fliser D; Speer T; Bals R
Kidney Int; 2021 Nov; 100(5):1081-1091. PubMed ID: 34237325
[TBL] [Abstract][Full Text] [Related]
20. Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.
Lu D; Bao D; Dong W; Liu N; Zhang X; Gao S; Ge W; Gao X; Zhang L
Lab Invest; 2016 Feb; 96(2):239-48. PubMed ID: 26641069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
